Holen Sie sich die Stockscreener-App
3.02
10.40%
0.28
Schlusskurs vom Vortag:
$2.74
Offen:
$2.79
24-Stunden-Volumen:
272.37K
Relative Volume:
0.34
Marktkapitalisierung:
$231.31M
Einnahmen:
$4.72B
Nettoeinkommen (Verlust:
$-123.85M
KGV:
-0.2112
EPS:
-14.2981
Netto-Cashflow:
$-303.12M
1W Leistung:
+14.15%
1M Leistung:
-22.24%
6M Leistung:
-82.02%
1J Leistung:
-82.02%
1-Tages-Spanne:
$2.74
$3.055
1-Wochen-Bereich:
$2.53
$3.055
52-Wochen-Spanne:
$1.885
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
Firmenname
Accendra Health Inc
Sektor
Branche
Telefon
(804) 277-4304
Adresse
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
3.0203 | 209.84M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
798.52 | 95.01B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
284.05 | 54.72B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
222.16 | 50.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
78.83 | 8.98B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.32 | 1.19B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2024-07-19 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-10-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Fortgesetzt | Citigroup | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-30 | Fortgesetzt | JP Morgan | Underweight |
| 2022-03-23 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2021-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-03-08 | Hochstufung | Goldman | Sell → Buy |
| 2020-12-17 | Hochstufung | UBS | Neutral → Buy |
| 2020-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-01-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2019-11-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2019-09-06 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-10 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-01-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-15 | Hochstufung | CLSA | Underperform → Outperform |
| 2018-12-14 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | Herabstufung | Goldman | Buy → Neutral |
| 2018-09-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | Herabstufung | CLSA | Outperform → Sell |
| 2018-04-10 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | Hochstufung | Goldman | Sell → Neutral |
| 2017-11-02 | Herabstufung | HSBC Securities | Buy → Hold |
| 2016-03-24 | Hochstufung | Goldman | Sell → Neutral |
| 2015-12-07 | Herabstufung | Goldman | Neutral → Sell |
| 2015-08-31 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | Eingeleitet | HSBC Securities | Underweight |
| 2009-08-05 | Hochstufung | Citigroup | Sell → Buy |
| 2008-12-01 | Herabstufung | HSBC Securities | Neutral → Underweight |
Alle ansehen
Accendra Health Inc Aktie (ACH) Neueste Nachrichten
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Canada
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Are Options Traders Betting on a Big Move in Accendra Health Stock? - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates by 60.9% as Loss Narrows to $0.04 Per ShareConsensus Forecast Report - newsline.com
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com Nigeria
Owens & Minor Appoints Jim Marshall as Chief Executive Officer, Effective May 27, 2026 - marketscreener.com
ACH - Finviz
Accendra Health Q1 2026 Earnings: EPS Beat Drives Positive Market ReactionShare Repurchase Impact - The Legal Advocate
Accendra Health launches debt exchange offer, seeks new financing By Investing.com - Investing.com Australia
Accendra Health launches debt exchange offer, seeks new financing - Investing.com UK
Accendra Health Launches Major Debt Exchange and Refinancing Plan - TipRanks
Accendra Health Launches Offering to Exchange Senior Notes - marketscreener.com
Accendra Health launches exchange offers to replace 2029/2030 notes with new secured notes, $326.25M new-money first-lien issue - TradingView
Accendra Health Announces Offers and Consent Solicitations - Yahoo Finance
Accendra Health (ACH) Edges Higher: Key Levels to Watch After +2.77% GainDiagonal Spread Trade - Newser
Owens & Minor Launches Halyard Kitting - Yahoo Finance
Accendra Health (ACH) shares jump after first-quarter earnings beat - MSN
Accendra Health, Inc. 8-K Filing Details: Company Information, Address, and Voting Results (May 14, 2026) - Minichart
Accendra Health Shareholders Approve Amended Omnibus Incentive Plan - TipRanks
Accendra Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ACH) 2026-05-14 - Seeking Alpha
Accendra Pays $19M To Settle IRS Transfer Pricing Matter - Law360
ACCENDRA HEALTH INCANNOUNCES OVER $1.5 BLN BALANCE SHEET OPTIMIZATION DEAL - Moomoo
Accendra Health 1Q Adj Loss/Shr 4c >ACH - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut - Investing.com India
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navi - GuruFocus
Accendra Health To Effectuate Balance Sheet Optimization Transaction in Near Term >ACH - Moomoo
Accendra Health 2026: Leading Home-Based Care Provider with Strong Financials, Growth Strategy, and Capital Structure Optimization – Minichart - Minichart
Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut By Investing.com - Investing.com South Africa
Accendra Health cuts debt by $100M, extends maturities, but slow growth keeps EBITDA outlook cautious. - Pluang
Healthcare Firm Accendra Inks Discount Debt Exchange, New Funds - Bloomberg.com
Accendra Health Makes Progress Addressing Its Debt Load (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Q1 2026 Earnings Transcript - AOL.com
Accendra Health earnings beat by $0.06, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Reports Q1 2026 Financial Results and Announces $1.5 Billion Balance Sheet Optimization Transaction - Minichart
Accendra Health 1Q 2026: Revenue $627.78M, EPS ($0.08) — 10-Q Summary - TradingView
Accendra Health (ACH) Q1 2026 loss, payor exit and major debt refi plan - Stock Titan
Accendra Health (ACH) Q1 Earnings Show Mixed Results - GuruFocus
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat - Yahoo Finance
Accendra Health 1Q Loss/Shr 8c >ACH - Moomoo
Finanzdaten der Accendra Health Inc-Aktie (ACH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.10%
3.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):